SEC Company Response from AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Jul 31, 2019
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: July 31, 2019 · CIK: 0000882291 · Accession: 0001683168-19-002394
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231397
Letter
Aethlon Medical, Inc.
9365 Granite Ridge Drive, Suite 100
San Diego, California 92123
August 1, 2019
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Thomas Jones
Tim Buchmiller
Re: Aethlon Medical, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-231397)
Acceleration Request
Requested Date: August 1, 2019
Requested Time: 1:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 1:00 P.M. Eastern Time on August 1, 2019 or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Julie Robinson of Cooley LLP at (858) 550-6092.
Very truly yours,
Aethlon
medical, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Aethlon Medical, Inc.
9365 Granite Ridge Drive, Suite 100
San Diego, California 92123
August 1, 2019
Via
Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Thomas Jones
Tim Buchmiller
Re:
Aethlon Medical, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-231397)
Acceleration Request
Requested Date:
August 1, 2019
Requested Time:
1:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 1:00 P.M. Eastern
Time on August 1, 2019 or as soon thereafter as is practicable.
If you have any questions regarding
this request, please contact Julie Robinson of Cooley LLP at (858) 550-6092.
Very truly yours,
Aethlon
medical, Inc.
/s/ James B. Frakes
James
B. Frakes
Chief Financial Officer